Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Pediatr Blood Cancer. 2009 Feb;52(2):169–176. doi: 10.1002/pbc.21873

Figure 1.

Figure 1

Mean plasma concentration-time profiles of SU5416 (●) and its two major metabolites, SU9838 (■) and SU6595 (□), for the initial weekly dose of 110 mg/m2 SU5416 in the group of 13 patients who were not taking enzyme inducing anticonvulsant drugs. Error bars depict the SD of the mean concentrations.